Clinical bottom line
Lymphedema-related symptoms are a significant source of discomfort and functional impairment in palliative care patients, particularly those with cancer or advanced chronic illnesses. Optimizing management involves a combination of patient education, self-care strategies, and symptom-targeted interventions to reduce swelling, pain, and skin complications. Evidence supports structured self-management education programs to improve symptom control and patient activation. However, symptom burden and treatment adherence can be challenging in advanced illness, necessitating individualized, multidisciplinary approaches. Further research is needed to clarify best practices specifically in palliative populations.
What the evidence shows
Lymphedema, characterized by abnormal accumulation of lymphatic fluid causing swelling, pain, and skin changes, is a common but under-recognized symptom in palliative care patients, especially those with cancer-related lymphatic disruption (Fu et al., 2015). The symptom complex includes heaviness, tightness, restricted mobility, and increased risk of infection, all of which can exacerbate suffering and reduce quality of life (Walker et al., 2018).
A quasi-experimental study by Cansız et al. (2022) demonstrated that a structured self-management education program significantly reduced lymphedema severity and related symptoms in patients with breast cancer-related lymphedema. The program improved patient compliance, daily living activities, and activation, highlighting the potential benefits of empowering patients with knowledge and skills to manage their symptoms. Although this study focused on breast cancer survivors, the principles of education and self-care are likely applicable to broader palliative populations.
Conservative management strategies include manual lymphatic drainage, compression therapy, skin care, and exercise, which aim to reduce swelling and prevent complications (Fu et al., 2015). These interventions require adaptation to the patient’s overall condition and goals of care, as intensive therapies may not be feasible or desirable in advanced illness. Symptom assessment tools such as the Integrated Palliative Care Outcome Scale (iPOS) can help identify lymphedema-related distress and guide tailored interventions (Roch et al., 2019).
Lymphedema symptoms may overlap with other distressing symptoms in palliative care, such as pain and mobility impairment, necessitating holistic assessment and management (Walker et al., 2018). Skin integrity must be closely monitored to prevent cellulitis and other infections, which can rapidly worsen patient status (Fu et al., 2015).
Caveats and uncertainty
Most evidence on lymphedema management derives from cancer survivorship or rehabilitation settings rather than explicitly palliative care populations. The applicability of intensive self-management programs in patients with limited prognosis or high symptom burden is uncertain. Adherence to compression therapy and exercise may be limited by fatigue, cognitive impairment, or comorbidities common in palliative care.
There is a paucity of randomized controlled trials evaluating lymphedema interventions specifically in palliative populations, and outcomes such as quality of life, symptom relief, and functional status remain under-studied. The heterogeneity of underlying diseases and patient goals complicates standardized management approaches.
Furthermore, the psychological impact of lymphedema, including distress related to body image and loss of independence, is not well characterized in palliative care and warrants further investigation (Walker et al., 2018).
How this may change practice
Palliative care clinicians should maintain a high index of suspicion for lymphedema-related symptoms in patients with cancer and other lymphatic impairments, incorporating routine assessment into symptom screening protocols. Early identification allows timely initiation of conservative management and education.
Implementing structured self-management education programs adapted to the palliative context may enhance patient engagement and symptom control. Multidisciplinary collaboration involving physiotherapists, nurses, and occupational therapists can facilitate individualized care plans balancing symptom relief with patient comfort and goals.
Clinicians should prioritize skin care and infection prevention, recognizing that cellulitis can rapidly destabilize palliative patients. Symptom burden and treatment feasibility must be regularly reassessed to align interventions with evolving patient needs.
Further research is needed to develop and validate palliative-specific lymphedema management guidelines and to explore novel therapies that may improve symptom control without undue burden.